پدیدآور آدم از آب و خاک Otologic Manifestations of Systemic Disease 1 granulomatous and infectious diseases neoplasms disorders of bone storage ID: 776600
Download Presentation The PPT/PDF document " به نام خداوند دادار پ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
به نام خداوند دادار پاک پدیدآور آدم از آب و خاک
Otologic Manifestationsof Systemic Disease
1
Slide2granulomatous and infectious diseases, neoplasms, disorders of bone, storage and metabolic diseases, Autoimmune and immunodeficiency disorders.
2
Slide33
Slide4I-GRANULOMATOUS AND INFECTIOUS DISEASES
1-LANGERHANS CELL HISTIOCYTOSIS formerly called histiocytosis X,(Lichtenstein ) eosinophilic granuloma, Hand-Schuller-Christian disease, Letterer-Siwe disease a proliferation of cytologically benign histiocytes Etiology: Idiopathic,, immunologic dysfunction that leads to unchecked proliferation of pathologic Langerhans cells-Unifocal eosinophilic granuloma in children and young adults, male predominance a solitary osteolytic lesion in the femora, pelvis, scapulae,vertebrae, ribs, mandible, maxilla, or skull, which includes thetemporal bone. The lesion may be asymptomatic, or it may cause pain, local swelling, or pathologic fracture. No systemic manifestations have been reported
4
Slide5--clinical course is typically benign, the prognosis is excellent, spontaneous regression may occur. Local curettage with or without low-dose irradiation (approximately 60 Gy) temporary splinting or casting may be necessary for weight bearing bones. Follow-up examination with a radiographic skeletal survey almost always found within 1 year.--Hand-Schuller-Christian disease multifocal form of LCH usually occurs in children younger than 5 years of age multifocal osteolytic lesions with limited extraskeletal involvement of skin, lymph nodes, and visceraSystemic manifestations fever, anorexia, recurrentupper respiratory infections, anterior cervical lymphadenopathy,otitis media, and hepatosplenomegalyThe classic triad osteolytic skull lesions, exophthalmos as a result of orbital bone involvement, and diabetes insipidus secondary to pituitarydisease may be seen in 25% of patients
5
Slide6Chest radiograph may show diffuse pulmonary infiltration, particularly in central and perihilar areas. Hilar lymphadenopathy is rare.Diagnosis requires biopsy of an accessible lesion. Spontaneous regression may occur, but the disease is typically chronic, andlow-dose chemotherapy may be required to control systemic manifestations.Letterer-Siwe disease a disseminated form of LCH in children younger than 3 years -diffuse involvement of multiple organs--- fever, seborrheic or eczema-like rash, oral lesions, lymphadenopathy, hepatosplenomegaly, multiple bony lesions, diffuse replacement of marrow with resulting blood dyscrasias, and pulmonary infiltration with respiratory failure. The disease is virulent, with a poor prognosis and a high mortality rate. Treatment consists of varying combinations of corticosteroids andcytotoxic drugs such as methotrexate, mercaptopurine, vincristine,vinblastine, chlorambucil, cyclophosphamide, and etoposide.High-dose chemotherapy and radiation followed by bone marrow transplantation or hematopoietic stem cell transplantation has been reported to be successful in a few advanced refractory cases of LCH
6
Slide7Otologic ManifestationsThe mastoid is a common site of involvement in LCH. When small, the lesion is asymptomatic. As it expands, it may manifest in several ways: by erosion of the posterior bony canal wall; by erosion through the cortex of the mastoid, zygomatic, or squamous portions; or by secondary infection The otic capsule and facial nerve are relatively resistant. Although sensorineural hearing loss (SNHL), vertigo, and facial nerve paralysis can occur, they are infrequent. Similarly, extension beyond the temporal bone to the jugular fossa and skull base is rare.The reported incidence of otologic manifestations in patients with LCH is 15% to 61%, and they may be the first sign of the disease. The most common symptom is otorrhea, followed by postauricular swelling, hearing loss, and vertigo.The most common sign is granulation tissue or aural polyps in the external auditory canal. The disease may manifest with perforation of the tympanic membrane, otitis media, otitis externa, fistula between the mastoid and the external canal, or nontender postauricular swelling. Occasionally, inner ear symptoms and a positive fistula test are found in the presence of an intact tympanic membrane.
7
Slide8The disease often mimics chronic otitis media, and mastoid surgery is frequently performed before the diagnosis is made.Diagnosis of LCH is suggested by 1) an inflammatory disorder of the middle ear and mastoid that does not respond to routine antibiotic therapy, 2) bilateral destructive ear disease, 3) an elevated erythrocyte sedimentation rate (ESR) in the absence of acute infection, 4) exuberant granulation tissue after mastoid surgery with a persistently draining cavity, 5) associated skin and systemic lesions. Radiographs show destructive lesions in the mastoid and temporal bonesThe diagnosis is established by biopsy; because the surface of the granulation tissue often shows infection, necrosis, and fibrosis, tissue should be acquired from deeper parts of the lesion.
8
Slide9Multiple eosinophilic granulomas in a 32-year-old woman.
Two lytic lesions of the skull show beveled edges (arrows) and nonsclerotic margins, which are typical of this disease
9
Slide10Irregular lytic lesion in the mastoid bone (
arrows) of a 13-year-old boy with unifocal eosinophilic granuloma
10
Slide1111
2-TUBERCULOSIS
I-GRANULOMATOUS AND INFECTIOUS DISEASES
The incidence of tuberculous otitis media has decreased dramatically.
During the early part of the twentieth century,
1.3
% to
18.6%
of all cases of chronic otitis media were
reportedly caused
by tuberculosis,
whereas
more recent studies
report tuberculous
otitis media rates of
0.05% to 0.9%.
The last
20 years
have witnessed an increase in incidence of tuberculosis,
however, caused in part by
the
aggressive nature of
tuberculosis in
individuals infected with
AIDS (HIV
)
And
by an emerging resistance to
antituberculosis drugs.
Mycobacterium tuberculosis is the infective organism
in
most
cases; occasionally, atypical mycobacteria (e.g.,
M.
avium
and
M. fortuitum) are
responsible.
Tuberculosis of the middle ear and mastoid may
occur
as
a
result
of hematogeneous or lymphatic spread
or
by
extension to
the middle ear cleft through the eustachian tube
.
Direct
inoculation through a perforation of the tympanic
membrane is
also possible.
Middle
ear involvement in the absence of
active pulmonary
disease is rare but may occur
Slide1212
During the early stages of tuberculous otitis media,
the tympanic
membrane becomes thickened, and the
otoscopic landmarks
become obliterated
.
Conductive hearing loss
results from
middle ear effusion, thickening of the tympanic
membrane and
middle ear mucosa, and destruction of the
ossicles
No
characteristic pain or tenderness
is evident
, but
lymphadenopathy
in the high jugular chain
occurs early.
Multiple small perforations
of the tympanic
membrane may
occur, with seropurulent drainage.
The perforations quickly
coalesce to cause loss of the tympanic membrane.
Likewise, a
myringotomy site in an intact tympanic membrane
may enlarge
quickly
.
The middle ear mucosa appears to be
hyperemic with
polypoid granulation.
Osseous Involvement
results
in the
sequestration
of bone and the destruction of the inner ear
, the
facial nerve, or both
.
Destruction of the
mastoid
tip
may result
in an asymptomatic, nontender
Bezold
abscess (a “cold
” abscess).
Rarely, tuberculosis can also manifest as
primary tuberculous petrositis
or as SNHL caused by
chronic
labyrinthitis
and
tuberculous
meningitis
Slide1313
The diagnosis of tuberculous involvement of the middle
ear is
usually delayed
.
The characteristic signs and
symptoms include
1
) multiple perforations of the tympanic
membrane that
quickly coalesce to form total tympanic membrane loss,
2) nontender cervical lymphadenopathy,
3
) intractable
otitis media
with polypoid granulation,
4) bony sequestration
.
Otic capsule
involvement
with resultant loss of auditory and vestibular
function may be the first symptom and indicates a
process that
differs from the more typical chronic otitis media
.
Definitive diagnosis
is made by histopathologic examination of
tissue from
the middle ear or mastoid, which shows a
granulomatous process
with multinucleated giant cells (Langerhans cells;
)and
histologic demonstration of acid-fast
organisms of tuberculosis
.
The accurate identification of
the mycobacterial
species and drug-resistant isolates by culture
is still
the gold standard, although culture is time consuming and
takes several weeks.
The
process is facilitated by the use
of several
different types of
nucleic
acid
amplification
tests
that have
been approved by the U.S. Food and Drug
Administration for
rapid identification of
M. tuberculosis
Slide1414
Multiple
perforations
of the tympanic membrane
,
exuberant polypoid
granulation
within the middle ear
,
and
early
loss of
inner ear
function
also are seen in
Wegener
granulomatosis (
WG
)
These two diseases are distinguished on the basis of
skin
tests for tuberculosis,
histologic
demonstration of
acid-fast
organisms of tuberculosis in granulation tissue,
cultures
of the
middle ear, the presence of
antineutrophil cytoplasmic antibodies
(ANCAs) in WG, and the systemic manifestations
of each
process
.
The mainstay of management of tuberculosis of the middle
ear and mastoid is the systemic use of standard antituberculous
chemotherapy.
Mastoid surgery may be required to
remove sequestrated
bone. Reconstructive surgery of the ossicles
and tympanic
membrane is feasible after the infection has
been controlled
.
Slide1515
I-GRANULOMATOUS AND INFECTIOUS DISEASES
3-WEGENER GRANULOMATOSIS
a
granulomatous
inflammatory process
with necrotizing
vasculitis
It
primarily affects the
upper and
lower respiratory tracts and kidneys
,
but it can
involve essentially
any organ in the body.
men = women
mean
age of onset is
40
years
.
Common presenting symptoms include
headache
,
sinusitis
,
rhinorrhea
,
otitis
media,
fever
, and
arthralgia
Upper
airway and
sinus
involvement occurs in
75% to 90%
of cases
.
Pulmonary manifestations
include cough, pleuritic chest pain, hemoptysis,
and nodular or cavitary infiltrates on chest radiography.
Pulmonary
manifestations occur in
65% to 85%
of cases
.
Other manifestations include
glomerulonephritis (60% to 75%
of cases
);
eye
involvement in the form of conjunctivitis, iritis, scleritis
, or
proptosis (15% to 50% of cases
);
and
dermatologic findings
of necrotic ulcerations, vesicles, or petechiae
.
Slide1616
normochromic normocytic
anemia
;
thrombocytosis
; positive
rheumatoid
factor; and
hyperglobulinemia
, particularly of IgA. The
ESR
is almost always elevated.
The discovery in 1985 of autoantibodies directed against the cytoplasmic constituents of neutrophils (antineutrophil cytoplasmic antibody [ANCA] and cytoplasmic ANCA [c-ANCA]) in patients with WG was a major advance in the diagnosis and understanding of WG.
A positive ANCA test, especially proteinase 3–specific c-ANCA, is very helpful in establishing or supporting a diagnosis of WG. The specificity of positive
c-ANCA testing in WG is greater than 95%; the sensitivity is variable and depends on the phase and type of WG. In more than 90% of patients with systemic and active WG, c-ANCA is positive; whereas in limited WG (e.g., ear or head and neck only or inactive disease), the sensitivity of c-ANCA is only 65% to 70%.
In addition, the antibody titer parallels the activity of the disease, although data conflict about the value in using the titer as a guide for immunosuppressive therapy.
The diagnosis of WG is made histologically by the presence of necrosis, granulomatous inflammation with multinucleated giant cells, vasculitis, and microabscess formation
Small biopsy specimens, however, such as those obtained from the ear or upper airway, may lack all of the various diagnostic features. In such cases, a diagnosis of WG can be made on the basis of the
clinical
presentation,
ANCA
testing, and
repeat
biopsy specimens taken from the same or related sites.
Slide1717
The etiology and pathogenesis of WG are unknown.
Infectious, genetic, and environmental risk factors and combinations thereof have been proposed.
The evidence to date suggests that WG is a complex, immune-mediated disorder in
which tissue injury results from the interplay of an initiating inflammatory event and a highly specific immune response.
Part of this response consists of the production of ANCA , directed against antigens present within the primary granules
of
neutrophils and monocytes; these antibodies produce
tissue damage
by interacting with primed neutrophils and
endothelial cells
.
The prognosis of WG
mortality
rate of 82%
before the era of
immunosuppressive therapy
current
remission rate of more than 75%
with appropriate
medical
therapy.
Induction of remission is
usually achieved
with high doses of corticosteroids, cyclophosphamide
, or
methotrexate given for 3 to 6 months
.
Maintenance of
remission is
achieved with lower doses of corticosteroids and less
toxic alternatives to cyclophosphamide, such as azathioprine
, methotrexate
, trimethoprim-sulfamethoxazole, or other
drug combinations
.
Other
therapies that have been used
include
leflunomide,
mycophenolate
mofetil,
and
the tumor
necrosis factor
inhibitors etanercept
and infliximab
.
Slide1818
Otologic
Manifestations
The middle ear and mastoid are the most common sites
within the
temporal bone that are involved in patients with
WG,
and WG may cause obstruction of the eustachian tube
with resultant
serous otitis media and conductive hearing loss
Some patients also have purulent otitis media,
and others
may have frank granulomatous involvement of
the middle
ear and mastoid.
The
process can extend to involve
the facial
nerve and inner ear, and this usually manifests as
rapidly progressive
SNHL and loss of vestibular function
.
Otologic disease
may be the sole and initial presenting feature in
some patients
with WG.
Slide1919
I-GRANULOMATOUS AND INFECTIOUS DISEASES
4-SARCOIDOSIS
Sarcoidosis is a chronic multisystem disorder of unknown
etiology characterized
by the
presence of noncaseating granulomas
.
It most frequently affects the
lungs
, although almost all
body parts
can be affected. The disease shows a
female
predominance and
is 10 times more common in
blacks
than in whites.
The onset
of disease is usually during the
third to fourth decade
of life
.
Common presenting manifestations include bilateral
hilar adenopathy
on chest radiography, cough, and
granulomatous skin
rash.
Other
manifestations include iridocyclitis, keratoconjunctivitis
, peripheral
lymphadenopathy, hepatosplenomegaly
, cardiac
failure, myalgia, and arthralgia. Neurologic
involvement includes
central and peripheral manifestations, and the
facial and
optic nerves are the most commonly affected cranial nerves.
Either peripheral mononeuritis or polyneuritis may be seen.
Laboratory findings may include hilar adenopathy on
chest radiography ,
hypercalcemia, and elevated
serum angiotensin-converting
enzyme
.
20
The etiology and pathogenesis of sarcoidosis are unknown.
The initial pulmonary lesion is an
alveolitis
characterized
by the
accumulation of CD4+ T cells; this is followed by
development of
noncaseating granulomas.
The
antigenic stimulus
that initiates
the disease process remains elusive.
Several possible associations
have been investigated that include
mycobacteria, certain
human leukocyte antigen complexes, abnormalities of
T cells and the T-cell antigen receptor, and involvement
of several
different
cytokines.
Spontaneous resolution occurs in many patients.
Corticosteroids are
beneficial for patients with progressive
symptoms or
with ocular, cardiac, or central nervous system (CNS
) involvement.
For patients who cannot tolerate or do
not respond
to corticosteroids, alternative drugs include methotrexate
, cyclophosphamide
, azathioprine, chlorambucil, cyclosporine
, chloroquine
, pentoxifylline, and antagonists of
human tumor
necrosis factor-α, such as etanercept and
infliximab.
Slide2121
Otologic Manifestations
Otologic manifestations of sarcoidosis
include
SNHL,
vestibular dysfunction
, facial nerve paralysis, and occasionally
granulomatous disease
of the external or middle ear and
mastoid.
The facial nerve is the most commonly affected cranial
nerve and
is usually involved as part of the symptom complex
of uveoparotid
fever (Heerfordt syndrome) characterized by parotitis
, uveitis
, facial nerve paralysis, and mild pyrexia
.
The
facial paralysis
may be sudden in onset, is often bilateral, and may
resolve spontaneously.
Histopathology
of the temporal bone
in sarcoidosis
has been reported in only one case; the main
findings were
perivascular lymphocytic infiltration and
granulomatous inflammation
that involved the cochlear, vestibular, and
facial nerves within the internal auditory
canal.
Slide2222
I-GRANULOMATOUS AND INFECTIOUS DISEASES
5-SYPHILIS
Congenital and acquired syphilis may affect the middle ear
in the
late latent and tertiary forms
.
In the
late latent
form,
the middle
ear and mastoid may be affected by a rarefying
osteitis with
leukocytic infiltration of the ossicles and mastoid bone
A similar but larger lesion of
tertiary
syphilis
, the gumma, shows obliterative arteritis and
central necrosis
.
A
gumma of the ear canal or middle ear may
result in
perforation
of the tympanic membrane and a
granulomatous appearance
of the middle ear mucosa
.
Definitive
diagnosis of
syphilis of the middle ear requires a
positive serologic test
and a
histologic demonstration of Treponema
pallidum
Syphilitic
involvement
of the tympanic membrane and middle ear
may mimic
tuberculosis
, and superinfection may result in
chronic otitis
media.
Inner ear involvement may occur in the absence of
macroscopic changes
in the tympanic membrane or middle ear
.
The
Hennebert
sign
, which is the induction of ocular deviation
with positive
or negative pressure in the external auditory canal,
was believed
to indicate a true fistula between the middle and
inner ear
as a result of rarefying osteitis of the otic capsule.
The more probable
cause is fibrous adhesions, however, between the
stapes footplate and the membranous labyrinth as a result
of endolymphatic hydrops.
Combined antibiotic and
corticosteroid therapy
is beneficial for the management of SNHL.
Slide2323
I-GRANULOMATOUS AND INFECTIOUS DISEASES
6-LYME DISEASE
Lyme disease is a multisystem inflammatory disorder that
primarily affects
the
skin
,
nervous
system,
heart
, and
joints
.
It
is caused
by the
spirochete Borrelia burgdorferi
, which is
transmitted
to
humans by certain
Ixodes ticks that are part of the
Ixodes ricinus
complex
.
The known primary reservoirs of the
disease
are
white-footed mice and white-tailed deer.
The
disease
was initially
recognized in 1975 because of a clustering of patients
with arthritis in
Lyme, Connecticut
, but it is now known
that Lyme
disease has been present for several decades in
Europe, where it is called Bannwarth syndrome
.
Infection is usually acquired in the
summer,
and
individuals of
all ages and both sexes can be affected
.
Three clinical stages
similar
to the stages seen with cases of
syphilis
are
recognized.
1-The
first stage, early localized infection, begins 3 to 33
days after
a tick bite with a characteristic skin lesion (
erythema migrans
). This lesion occurs in 60% to 80% of patients
and may
be accompanied by minor constitutional symptoms
.
2- The second
stage, early disseminated infection, occurs within
days or
weeks after inoculation and begins with
hematogeneous dissemination
of the organism from the site of inoculation
. The
symptoms, which mimic a systemic viral illness, include
fever, migratory arthralgia, myalgia, headache, meningismus
, generalized
lymphadenopathy, malaise, fatigue, and
secondary annular skin lesions.
Slide2424
After hematogenous spread,
B. burgdorferi seems to be able
to sequester itself in certain niches and can cause localized inflammation in the nervous system, heart, or joints.
Neurologic
involvement is manifested by
meningitis
,
encephalitis
, cerebrospinal fluid
lymphocytosis
, peripheral
neuropathy
,
myelitis
, or cranial
neuropathy
that includes
facial nerve paralysis
Cardiac
manifestations include atrioventricular block or other
arrhythmias
,
myocarditis
, and
pericarditis
.
Joint
disease manifests as brief attacks of asymmetric
oligoarticular
arthritis,
primarily in large joints and especially the knee.
3- The third stage, late or persistent infection, occurs more than 1 year after onset and can result in chronic, prolonged arthritis; chronic encephalomyelitis; chronic axonal peripheral polyradiculopathy; keratitis, similar to syphilis; acrodermatitis chronica atrophicans; and localized scleroderma-like lesions.
A patient may experience one or all of the stages, and the infection may not become symptomatic until the second or third stage.
Affected tissues show infiltration by lymphocytes and plasma cells. Mild vasculitis and hypercellular vascular occlusion can occur, but tissue necrosis generally does not.
Granulomas
,
gummas, multinucleated giant cells, and fibrinoid necrosis
have not been observed, in contrast to the findings in patients with
syphilis
.
Slide2525
In recent years, the complete genome of the spirochete has been sequenced, and animal models have been developed for studying the pathogenesis of Lyme disease using mice and primates. The animal models have shown that inflammatory
innate immune responses are critical in the pathogenesis of the disease and that genetic factors may be important in determining the severity of some of the manifestations.
The diagnosis of Lyme disease is usually based on the recognition of the characteristic clinical features, a history of exposure in an area where the disease is endemic, and detection of
a
specific antibody to
B. burgdorferi by enzyme-linked
immunosorbent
assay
and Western
blotting.
The antibody test
must be
interpreted properly using the criteria of the Centers
for Disease
Control and Prevention, because false-negative
and false-positive
results can occur. In addition,
B. burgdorferi
may
cause
asymptomatic infection, in which case the symptoms
caused by another disease may be wrongly attributed to
Lyme borreliosis.
The spirochete is highly sensitive to
doxycycline
but
only moderately
so to
penicillin
. Other effective antibiotics
include
amoxicillin
,
erythromycin
,
cefuroxime
,
ceftriaxone
,
Steroids have
been used for severe carditis and arthritis
.
Among patients
managed early in the course of the disease, the
specific antibody
response usually disappears within months,
and patients
may become reinfected in the future. Among
patients with
late manifestations, such as arthritis, titers decline
after successful
management, but patients remain seropositive.
Although two vaccines were developed and found to be
effective in
clinical trials, they are not currently being marketed.
Slide2626
Otologic Manifestations
Facial
nerve
paralysis
is the most common otologic manifestation
, with
a reported incidence of
3%
to
11%
;
it may
be
bilateral
in 25%
of cases. This type of paralysis is seen in
the
second
stage
of the disease, and it affects patients of all
ages and
both sexes.
The
onset is acute, the duration is weeks to
a few
months, and the return of function is spontaneous and
is usually
complete. There may be a history of preceding otalgia
, ipsilateral
facial pain, or
paresthesias.
Although other
neurologic features
of the second stage may be seen, facial nerve
paralysis can occur as the sole neurologic abnormality.
Antibiotics and steroids do not seem to influence the
duration or
outcome of facial
paralysis,
but they are
recommended to
treat concurrent symptoms and to prevent the more
serious late
complications
.
There is no role for surgery
.
The
precise cause
and histopathology of facial nerve palsy have not
been elucidated
. Histology from other involved peripheral
nerves shows
perineural and perivascular infiltration by
lymphocytes and
plasma cells. In chronic and severe neuropathies,
demyelination and
loss of nerve fibers similar to wallerian
degeneration occur.
It is unclear whether neural lesions result from
an inflammatory response to the spirochete or represent
an immune-mediated
epiphenomenon.
A well-documented otologic manifestation is an
unusual skin
lesion called a
lymphocytoma
, in which intensely red
and
violet
nodules occur on the earlobe during the second stage
of disease.
The lesion consists of benign but hyperplastic
lymphocytic follicles
in the
dermis.
Auditory and vestibular manifestations such as SNHL
, sudden
hearing loss, positional vertigo, and Meniere-like
symptoms have
been
described.
More clinical data and
temporal bone
studies are needed to substantiate these preliminary
observations.
Slide2727
I-GRANULOMATOUS AND INFECTIOUS DISEASES
7-MYCOTIC DISEASES
Fungi are ubiquitous in the environment and are of low
intrinsic virulence
. Systemic invasive clinical disease reflects
some defect
in host defenses, such as diabetic ketoacidosis,
chemotherapy for
malignancy, corticosteroid therapy, or
acquired immunodeficiency
syndrome (AIDS).
Aspergillosis
, mucormycosis
, candidiasis
, cryptococcosis, coccidioidomycosis, and
histoplasmosis are
systemic mycoses that can cause
disseminated disease
and may involve the temporal bone
.
Diagnosis is
made by
biopsy and culture, and treatment consists of control of
the underlying predisposing condition, surgical
debridement of
necrotic tissues, and systemic chemotherapy, usually
with amphotericin
B
.
Otologic Manifestations
The middle ear and mastoid can be involved as a result
of ascending
infection along the eustachian tube and
tensor tympani
, which is often seen in mucormycosis
,
or through superinfection of existing chronic otitis
media.
Destruction of the middle ear cleft ensues, often with
extension to
the surrounding structures, including thrombosis or
rupture of
the internal carotid
artery.
Other routes of infection
include hematogeneous
embolic dissemination, which can result
in multiple
granulomas throughout the temporal bone,
and through
cryptococcal involvement of the CNS, which can
cause invasion
and degeneration of the nerve trunks in the
internal auditory canal.
Slide2828
I-GRANULOMATOUS AND INFECTIOUS DISEASES
8-CYTOMEGALIC INCLUSION DISEASE
Cytomegalic inclusion disease is caused by infection by
the cytomegalovirus
(CMV). Cochlear involvement may be
congenital or
reactivated from a latent state, particularly in
immunocompromised patients
.
In
the congenital form,
infection may
result in hepatic injury, brain injury, mental retardation
, blindness
, and deafness.
The
hearing loss caused by
cytomegalic inclusion
disease is variable and may be progressive
or sudden
in
onset.
Temporal bone histopathology of cytomegalic
inclusion disease
shows characteristic inclusions within the middle
and inner
ears that includes the nonsensory elements of
both cochlear
and vestibular systems
Slide2929
II-NEOPLASTIC DISEASESneoplasms of the temporal bonethree neoplasms—multiple myeloma, leukemia, and metastatic 1-MULTIPLE MYELOMA
Multiple myeloma is a malignancy of plasma cells derived
from B
lymphocytes, and its major feature is the demonstration
of an
abnormal monoclonal protein (M component) in blood
, urine
, or both.
There
is a slight
male
predominance, and
the median
age of onset is
60 years
. Clinical manifestations are
the result
of multiple plasma cell tumors and consist of severe
bone pain
, pathologic fractures, failure of the bone marrow, renal
failure, hypercalcemia, and recurrent infections.
Laboratory findings include the demonstration of the
M component
on serum or urine electrophoresis,
normochromic normocytic
anemia, hypercalcemia, and elevated blood
urea nitrogen
levels.
Typical
radiographic findings include
punchedout osteolytic
lesions, which are particularly well seen on
lateral skull
radiography.
Bone
marrow aspirates show infiltration
by plasma
cells.
Slide3030
For decades, the mainstay of therapy has been the use of alkylating agents, such as melphalan and corticosteroids; with this regimen, the median survival is approximately 3 years.
Important advances have been made more recently that have substantially altered therapy for patients with myeloma. These advances include the use of hematopoietic cell transplantation; improved supportive care measures, such as the use of bisphosphonates and erythropoietin; and novel agents such as thalidomide, lenalidomide, and bortezomib.
Occasionally, only one plasma cell tumor (without marrow plasmacytosis) can be found. These lesions can occur in bone (solitary bone plasmacytoma) or soft tissue (extramedullary plasmacytoma), including the temporal bone.
Both lesions can
affect younger individuals, are associated with an M component
in less than 30% of the cases, and have an indolent course
with survival
rates of 10 years or more
.
Local radiotherapy (40 Gy
) is
usually sufficient management.
Periodic
evaluation of
serum and
urine globulins and a skeletal radiographic survey
should be
performed to detect conversion to multiple myeloma.
Slide3131
Coronal computed tomography scan shows a large
, destructive
lytic lesion (
arrows) of the clivus (CL), petrous temporal bone
,
middle
ear, and jugular foramen area caused by multiple myeloma in
a 72-year-old
man. The presenting symptoms were
facial nerve paralysis
and
otorrhea
.
Slide3232
Coronal computed tomography scan with
contrast enhancement and a soft tissue algorithmshows a slightly enhancing mass that has destroyed the mastoid bone and extends to the posterior fossa (PF) and upper neck (UN).
UN
PF
Slide3333
Otologic Manifestations
The temporal bone is frequently involved in cases of
multiple myeloma
. Radiography may show rounded lytic lesions of
the calvaria
and temporal bone
At a microscopic
level, the marrow spaces of the petrous bone are
commonly replaced by myeloma cells, and discrete lytic
bone lesions
may be seen in the otic capsule
Symptoms referable
to temporal bone involvement are usually overshadowed
by manifestations of diffuse disease. Occasionally
, these
symptoms may be the presenting feature of
myeloma,
or they may be the only evidence of disease (plasmacytoma
of the
temporal bone
).
Symptoms are nonspecific and
include hearing
loss, tinnitus, vertigo, otalgia, and facial paralysis
Slide3434
II-NEOPLASTIC DISEASES
2-LEUKEMIA & LYMPHOMA
Leukemic infiltrates may occur in the temporal bone. They
are common
in the submucosa of the pneumatized areas of
the middle
ear and mastoid, including the tympanic
membrane and
in the bone marrow of the petrous
apex
Secondary
bacterial infection of the middle ear
and mastoid
often results from an immunocompromised state
that is
a result of either the disease itself or chemotherapy
.
Hemorrhage commonly
occurs in association with infiltrates and
can
occur in the middle ear, mastoid, or inner ear
.
Clinical manifestations include
middle ear effusion, acute and chronic
suppuration in
the middle ear and mastoid, thickening of
the tympanic
membrane, conductive hearing loss, SNHL (
including sudden
SNHL), vertigo, facial paralysis, and skin lesions
in the
auricle or external auditory
canal.
Granulocytic sarcoma, or chloroma
, is a localized
extramedullary tumor
composed of immature myeloid cells. It is
related to
acute or chronic myelogenous leukemia, and its
appearance may
precede, coincide with, or follow the diagnosis of leukemia.
Such a lesion can occur in the temporal
bone,
and
otologic manifestations
can constitute the initial presentation
.
Management is
by local irradiation and systemic chemotherapy.
LYMPHOMA
Similar to leukemic infiltrates in the inner ear, both
Hodgkin and
non-Hodgkin lymphomas may result in hearing loss
by either
hemorrhagic or malignant infiltrative lesions of
the middle
and inner ear
Slide3535
II-NEOPLASTIC DISEASES
3-METASTATIC
NEOPLASMS
hematogeneous
dissemination
breast,
lung,
prostate,
and
skin
The lesions are usually
destructive and
osteolytic
however
, some lesions, such
as those
from the prostate or breast, may be osteoblastic
.
The petrous
apex and internal auditory canal seem to be sites
of predilection
for metastases, although any part of the
temporal bone
may be involved
The otic capsule seems
to be
resistant to neoplastic
invasion.
Although otologic manifestations infrequently are the
first evidence
of malignant disease, more often they are
preceded by
other systemic symptoms. Involvement of the external canal
, middle
ear cleft, or eustachian tube may cause conductive
hearing loss and pain; involvement of the otic capsule
may produce
SNHL, vertigo, and facial nerve paralysis
.
In
meningeal carcinomatosis
, rapidly progressive unilateral or
bilateral SNHL
is a common presenting
symptom.
Unilateral
SNHL may
mimic a cerebellopontine angle tumor, and bilateral SNHL
may mimic immune-mediated inner ear disease
.
Diagnosis
is made
by cytology of the cerebrospinal fluid.
Slide3636
Axial computed tomography scan of an
82-year-old woman
with metastatic breast adenocarcinoma showing a large lytic
lesion (
arrows) destroying the mastoid, squamosa, otic capsule, and labyrinth.
Slide3737
III-DISEASES OF THE BONE
Paget disease, osteogenesis imperfecta, and osteopetrosis can sometimes mimic the clinicalfeatures of otosclerosis.
1-PAGET DISEASE
Paget disease of bone (
osteitis deformans
) is a chronic
and sometimes
progressive disease of unknown etiology
characterized by
osteolytic and osteoblastic changes that mainly
affect the
axial skeleton.
Genetic
factors play a role in the
pathogenesis of
Paget disease, which may be inherited in an
autosomal dominant manner
with high penetrance. Four susceptibility
loci have
been identified, one on chromosome 18, one on
chromosome 6
, and two on chromosome
5.
Mutations in the
SQSTM1
gene
that encodes the sequestosome 1 protein have been
found in
some individuals.
Viral
infection also seems to play a role
in the
etiology of Paget disease, based on electron microscopy
and immunohistochemical studies.
It is possible that the
disease develops
from a slow virus infection in susceptible individuals
who have an underlying genetic predisposition.
Paget disease affects
3%
of the population
aged 40 years
and older
and 11% of the population aged 80 years and
older.
Men
are affected more commonly than
women
Slide3838
. The onset of clinical manifestations is usually in the sixth decade of life and includes enlarging skull; progressive kyphosis; and deformities of the pelvis, femur, and tibia.
Radiographic findings include a thickened skull table; patchy, ill defined
densities of the skull; and poor definition of the cortical margins of the inner ear and internal auditory canal, particularly in the lytic phase of the disease.
The bisphosphonates, which inhibit the resorption of bone
, constitute the
mainstay of medical therapy for symptomatic Paget disease.
Other antipagetic drugs include calcitonin, mithramycin, ipriflavone,
and gallium nitrate.
Slide3939
Lateral skull radiograph of a patient with Paget disease
.
(
osteitis deformans
)
Findings include thickening of the skull table, multiple patchy densities,
and
platybasia
.
Slide4040
Axial computed tomography scan of a 75-year-old
man with
Paget
disease
(
osteitis deformans
)
.
Diffuse
expansion of the skull table and involvement
of both
temporal bones with patchy demineralization is apparent.
Slide4141
Otologic Manifestations
Clinical manifestations of Paget disease include hearing loss
, tinnitus
, and mild vestibular dysfunction.
The
facial nerve
is spared.
Hearing loss occurs in 5% to 44% of
patients
and
may be
sensorineural, mixed, or, rarely, conductive only.
Most
often
, the
loss is mixed, with a descending pattern for bone
conduction and
relatively flat air-conduction thresholds. Hearing
losses are progressive and are greater than those of
age-matched healthy
subjects. Distinguishing features of Paget disease
— compared
with otosclerosis, which is the most common
differential diagnosis—include
a later age of onset, in the
sixth
decade; greater SNHL, with a descending pattern;
enlarged calvaria
; enlargement and tortuosity of the superficial
temporal artery
and its anterior
branches;
elevated serum alkaline
phosphatase level
; and radiographic evidence of pagetic changes in
the temporal bones.
None of the many published clinical and histologic
reports have
clearly identified a consistent pathologic basis for
these hearing losses;
specifically, the apparent conductive
hearing loss
is not caused by ossicular fixation, and SNHL is not caused
by the compression of cochlear nerve fibers.
Attempts
at
the surgical
correction of conductive loss are generally not considered
worthwhile.
Monsell and colleagues73,74 reported a
statistically significant
correlation between the bone mineral
density of
the cochlear capsule (measured in vivo by quantitative
computed tomography
) and the high-frequency pure tone
air conduction thresholds
and the air-bone gap in patients
with Paget
disease of the skull. It is unclear whether this finding
is only
a marker of disease effect or a phenomenon closely
related to
the mechanism of hearing loss.
Slide4242
The histopathologic appearance of pagetic bone is
variable and
depends on the relative osteoclastic and osteoblastic activity.
Typical findings include osteoclastic resorption of
marrow containing
bone with an increase in vascularity and
formation of
fibrous tissue
.
New bone formation occurs in an
irregular manner
and produces its typical mosaic pattern as a result
of irregular
and curved cement
lines
Pagetic
bone changes
occur in three phases
:
1) an initial osteolytic phase,
2) a
mixed or combined phase
,
and 3) an osteoblastic or “
burnt out” phase.
In the temporal bone, a fourth phase can be identified
, which
is the remodeling of inactive pagetic bone
into normal-appearing
lamellar
bone.
The disease usually
begins in
periosteal bone and extends to involve enchondral and
endosteal bone
.
Slide4343
III-DISEASES OF THE BONE
2-OSTEOGENESIS
IMPERFECTA
Osteogenesis imperfecta (OI), also known as
van der
Hoeve–de Kleyn
syndrome
,
is a genetically determined disorder of
the
connective
tissue characterized clinically by fragile bones
that break
with minor trauma
.
Approximately 80% to 90%
of patients
with OI have mutations of one of the two type 1
collagen genes
,
COL1A1 and COL1A2. Many hundreds of
unique
mutations
of these two genes have been identified in
individuals with
OI. The older terms
osteogenesis imperfecta congenita
and osteogenesis
imperfecta tarda have been replaced by a
classification
system
that defines four types of OI based on clinical features
, radiologic
criteria, and mode of inheritance
.
Slide4444
--
OI type 1
has an autosomal-dominant mode of inheritance.
It is the
mildest
form and is associated with blue sclerae, non deforming
fractures, and normal stature. Hearing loss is common and occurs in 30% to 50% of cases.
--
OI type 2
is the
most severe form
, in which multiple fractures occur in utero
and often result in stillbirth. This type either is acquired as a sporadic new mutation or is inherited in an autosomal-recessive manner.
-- OI type 3
is characterized by multiple fractures, progressive
bone deformity during childhood and adolescence, and sclerae that are bluish at birth but white later in life. Hearing loss occurs in about 50% of individuals. The long
bones may be slender and bowed with abrupt widening near the epiphyses. Kyphoscoliosis, pectus excavatum, weak joints, dental abnormalities, and wormian bone in the skull table are common The mode of inheritance varies; it may be autosomal dominant, autosomal recessive, or the result of a new mutation.
--
OI type 4
is a dominantly inherited
form; it is similar to OI type 1 except that the sclerae are white
(normal). Hearing loss is less common than it is with type 1
and occurs in 10% to 30% of
cases.
Management consists of the treatment of fractures,
orthopedic surgery
to correct deformities, use of orthotic devices
, and
physical and occupational therapy. Bisphosphonate
therapy is
being increasingly used, because these drugs are potent
inhibitors of bone resorption and bone
turnover.
Other
therapies under
investigation include use of growth hormone and
allogeneic bone marrow transplantation.
Slide4545
Lateral radiograph of the skull in a patient with
osteogenesis imperfecta
.
Wormian bone
is seen, particularly in the posterior table.
Slide4646
Radiograph of the arm of a patient with
osteogenesis imperfecta
. A pathologic fracture, demineralization of the humerus, and
gross abnormalities
of the elbow joint are evident.
Slide4747
Otologic Manifestations
Conductive
hearing loss and
SNHL
occur in patients with OI.
Severe SNHL
has been estimated to occur in
approximately
40
%
of patients and has a high correlation with
gray or
white sclerae
.
Conductive
hearing loss usually accompanies
blue sclerae
, which first becomes apparent by
20 to 25 years
of
age and
then becomes severe enough to cause the patient to
seek medical
attention
15 to 20 years later
.
No relationship
has been
found between hearing loss and frequency or severity of
fractures.
Some patients with mild OI come to medical
attention with
conductive hearing loss similar to that seen with otosclerosis.
Early age of onset of hearing loss, high
compliance values
on tympanometry, a history of fractures after
minor trauma
in childhood that ceased after puberty, a family
history of
OI, and blue sclerae are helpful diagnostic clues.
The conductive loss reflects structural changes in the ossicles.
Microfractures of the manubrium
,
fragility of the long process of the incus
, and
fracture or resorption of the crura of the stapes
have been
reported.
The stapedial footplate
is typically
described as thick, soft, and chalklike or granular
, and
it is usually
fixed
.
Rehabilitation can be accomplished
by amplification
or
surgery.
A stapedectomy can give
results similar
to those seen with otosclerosis, but the procedure
is extremely
delicate. Crimping the prosthesis around the incus
may cause a pathologic fracture, and a platinum ribbon is
preferred to
stainless steel
wire.
Slide4848
Histopathology of the temporal bone in cases of OI type 2 has shown deficient ossification of the endochondral layer of the otic capsule, which shows increased amounts of fibrous tissue with numerous blood vessels. The periosteal layer is often thin and deficient , and the stapes crura are often thin and incomplete.
The
otopathology in cases of OI type 2 is very similar if not identical to that seen in cases of otosclerosis
. The abnormal bone involves the periosteal and endochondral layers of the
otic capsule
and may result in the fixation of
the stapes footplate.
Slide4949
III-DISEASES OF THE BONE
3-FIBROUS
DYSPLASIA
Fibrous dysplasia is a benign, chronic, slowly progressive
bone disorder
of unknown etiology characterized by the
replacement of
normal bone with a variable amount of fibrous tissue
and woven
bone
.
It may occur as part of
Albright
syndrome
—characterized
by multiple bony lesions, abnormal pigmentation
, endocrine
dysfunction, and precocious puberty in
girls—or it may exist alone in the monostotic or
polyostotic form.
The
monostotic
form is more common and usually
occurs in
the skull, ribs, proximal femur, or tibia.
In
the
polyostotic
form
, skull lesions are seen in more than 50% of patients.
Clinical manifestations of fibrous dysplasia include
bony deformity
, pathologic fracture, and cranial nerve palsies.
The disease
starts early in life, usually in childhood; the
monostotic form
may become quiescent at puberty, whereas the
polyostotic form
can continue to progress
.
Sarcomatous
transformation
can
occur, and incidence is estimated at
0.4%.
Laboratory findings
include an elevated serum alkaline phosphatase
level in
30% of patients with polyostotic fibrous dysplasia,
with usually
normal serum calcium and phosphorus levels.
The typical
radiographic findings include a radiolucent area with
a well-defined
smooth or scalloped edge and a
ground-glass appearance
. Areas of increased radiodensity may also be
seen
Slide5050
The histopathology of fibrous dysplasia consists of the replacement of normal cancellous bone by a fibrous stroma arranged in a whorled pattern. A variable
amount of irregularly arranged spicules of woven bone cause
the ground-glass radiographic changes
The lesion is composed
of immature mesenchymal osteoblastic precursor cells.
An activating mutation is present in the gene that encodes the
α-subunit of stimulatory G protein. Elevated levels of cyclic
adenosine monophosphate result that affect the transcription
and expression of multiple downstream genes, which
ultimately result
in the pathologic
lesion
Treatment consists of bisphosphonate
therapy and orthopedic surgery for correction of
deformities and treatment of pathologic fractures
Slide5151
Lateral radiograph of the skull of a patient with
fibrous dysplasia showing lytic (L) and fibrous (F) phases of disease. Spicules of new bone are responsible for the ground-glass appearance of the fibrous phase.
F
L
Slide5252
Coronal tomographic radiograph of a patient with
fibrous dysplasia. New bone formation causes a dense appearance of the involved left temporal bone.
L
Slide5353
Fibrous dysplasia.
The
irregularly arranged spicules
of woven
bone in a fibrovascular stroma show a whorled pattern (×64).
Slide5454
Otologic Manifestations
The temporal bone occasionally may be involved in cases
of fibrous
dysplasia, with about 100 cases reported to
date.
the
monostotic form occurred in 70%,
the
polyostotic
23
%
,
Albright
syndrome
7
%
All parts of the temporal bone can be involved, but the
process generally
begins as a painless, slowly progressive swelling
that involves
the mastoid or squama. Progressive narrowing of
the external
auditory canal with conductive hearing loss is the
most common
manifestation and occurs in about 80% of cases. This
narrowing may be mistaken for
exostoses
, but fibrous
dysplasia is
encountered during the second or third decade of life;
at surgery
, it is vascular with a characteristic soft, spongy, and
gritty consistency.
Entrapment of keratin debris medial to a
stenotic canal
can cause an external canal cholesteatoma.
Involvement of
the middle ear and ossicles or obstruction of the eustachian
tube also can cause conductive hearing loss.
Erosion
of the
fallopian canal
with facial nerve paralysis or erosion of the otic
capsule with SNHL and vertigo is seen occasionally.
An isolated lesion
of the mesotympanic bone can simulate a
glomus
tympanicum
tumor that can manifest as a reddish mass
behind an
intact tympanic membrane, with pulsatile tinnitus and
hearing loss.
Slide5555
Management of fibrous dysplasia is symptomatic.
Operative procedures should be limited to biopsy and relief of functional deficits.
Stenosis of the external canal often requires surgical removal with canalplasty and meatoplasty. Restenosis as a result of regrowth of fibrous dysplasia occurs, and multiple procedures are sometimes needed.
Compared with simple canalplasty, a
postauricular canal-wall-down mastoidectomy
with wide canalplasty and skin grafting gives better results, with long term
canal patency.
Radiotherapy is contraindicated
an increased rate of malignant degeneration
Long-term follow-up is indicated because of the potential for facial nerve
involvement and for the progression of conductive hearing loss to profound SNHL
Slide5656
III-DISEASES OF THE BONE
4-OSTEOPETROSES
Osteopetroses are rare genetic disorders characterized
by greatly
increased bone
density.
Osteopetroses result
from the
defective function of
osteoclasts
, which leads to a
failure of
normal bone resorption
, while normal bone formation
by osteoblasts
continues with deposition of excessive
mineralized osteoid
and cartilage.
Four
types of osteopetrosis have
been defined
, although patients with atypical symptoms are numerous
, which
suggests that additional types likely exist
.
1.
Malignant
osteopetrosis is an autosomal-
recessive
form
that
manifests
in
infancy
, is rapidly progressive, and has a high
mortality rate
. Many cases have been shown to be due to
mutations in
the gene that encodes for the TCIRG1 subunit of the vacuolar
proton pump within osteoclasts. The disease is
characterized by
the encroachment of bone marrow that leads to anemia
, thrombocytopenia
, hepatosplenomegaly, increased
susceptibility to
infection, and encroachment of the neural foramina,
which causes neural degeneration.
Optic
atrophy, facial paralysis
, SNHL
, hydrocephalus, and mental retardation are common
, and
death usually occurs during the first or second decade
of life.
The only effective treatment is bone marrow transplantation
.
Slide5757
2.Another type of autosomal-
recessive
osteopetrosis is due to a mutation in the gene for cytoplasmic carbonic anhydrase II. This type is very rare (approximately 50 cases have been reported), and it is associated with distal renal tubular acidosis.
3. Autosomal-dominant
type 2 osteopetrosis, also known as
Albers- Schِnberg
disease and
marble bone disease
, is the
most
frequent
type
. It is associated with normal life expectancy and may
be asymptomatic
.
Many
cases have been shown to result
from mutations
in the
CLCN7 chloride-channel
gene.
Clinical
manifestations
include an increased incidence of
fractures (
osteopetrotic bone is fragile despite its solid appearance
); osteomyelitis
of the mandible from dental infection;
progressive enlargement
of the head and mandible; clubbing of
the long
bones; and cranial neuropathies such as progressive
optic atrophy
, trigeminal hypesthesia, recurrent facial paralysis,
and SNHL
. Patients may have syndactyly of the fingers or toes
and abnormal
fingernails; these abnormalities can aid the
physician in
making the clinical diagnosis
.
Radiographic
evaluation reveals
a great increase in the density of all bones
.
4. Autosomal-dominant
osteopetrosis type 1 is an extremely
rare
type
reported in only three families, and it seems to be
linked to
a locus on chromosome
11q12-13.
Patients with this
type of
osteopetrosis are often asymptomatic, but some have
pain and
hearing loss
.
This is the only type of osteopetrosis
not associated
with an increased rate of fractures.
Slide5858
Otologic Manifestations
The endochondral layer of the otic capsule and ossicles in
the temporal
bones of infants and children with the
malignant recessive
form of osteopetrosis consist mainly of dense
calcified cartilage. The
mastoid is not pneumatized, and the
stapes persists
in fetal form
The
inner
ears appear
normal. Dehiscence of the tympanic segment of
the window
niche, has been a consistent finding
.
However,
no observable
nerve compression is evident. These children
often have
recurrent episodes of acute otitis media, serous
otitis media
, stenosis of the external auditory canal,
conductive hearing
loss or SNHL, and unilateral or bilateral facial
nerve paralysis.
In the more benign adult form (autosomal-dominant type
2 osteopetrosis
), the temporal bone is markedly sclerotic
with obliteration
of the mastoid air cells and a narrowing of
the eustachian
tube and the external and internal auditory canals.
Exostotic overgrowth of the periosteal bone surrounding
the tympanic
cavity can occur
,
with ankylosis of
the ossicles
and obliteration of the oval and round window niches
These changes explain the common finding
of conductive
hearing loss. SNHL also occurs, but the inner
ears appear
normal. Narrowing of the eustachian tube
predisposes a
patient to serous otitis
media.
Recurrent acute facial
nerve paralysis
that is similar to Bell palsy, involving one or both sides
, is
a frequent manifestation. The tendency is toward progressive
residual weakness with each episode. Radiographic
studies should
be performed in any child or
young
adult with
recurrent facial
nerve paralysis to determine the possibility of osteopetrosis.
Total decompression of the facial nerve has been
advocated to
ameliorate recurrent palsies
Slide5959
Recessive osteopetrosis of the temporal bone of
a 15-month-old boy. The endochondral layer of the otic capsule and stapes is composed of calcified cartilage (×12.3).
Higher magnification of the temporal
bone The calcified cartilage (CC) of endochondral bone appears as densely staining, round-to-ovoid profiles (×396).
CC
Slide6060
Osseous obliteration of the round window niche (RWN
) .
Fluid is apparent in the niche adjacent to the round window membrane (RWM; ×18).
Osteopetrosis in a 30-year-old man shows overgrowth of dense lamellar bone around the epitympanum with jamming of the malleus (M) and incus (I). The facial nerve canal (FC) is narrowed (×9). A, antrum; LSCC, lateral semicircular canal.
FC
M
I
A
LSCC
RWM
RWN
Slide6161
III-DISEASES OF THE BONE
5-OSTEITIS
FIBROSA CYSTICA
Osteitis fibrosa cystica, also known as
von Recklinghausen disease
,
is
a bone lesion caused by
excess parathyroid hormone
, and
it is
characterized in classic cases by
osteoclastic bone resorption
, marrow
fibrosis, bone cysts, bone pain, and fractures
.
In
most cases
, it is caused by primary hyperparathyroidism, usually
because of an adenoma.
Other
manifestations relate to
hypercalcemia and
hypercalciuria
.
Although the temporal bone
can be
affected in this
disorder,
it is very rare in clinical practice.
The otic capsule is replaced by abnormal bone
composed of
loosely arranged trabeculae of varying sizes and shapes
interspersed with
marrow spaces that contain fibrous tissue.
SNHL has
been attributed to osteitis fibrosa that involves the temporal
bone.
Slide6262
IV--STORAGE
AND
METABOLIC DISEASES
1-MUCOPOLYSACCHARIDOSES
The mucopolysaccharidoses (MPS) are a group of
diseases caused
by an inherited deficiency of one of several
lysosomal enzymes
that
degrade mucopolysaccharides
. As a result,
undergraded mucopolysaccharides
accumulate intracellularly, which
gives rise to large cells with vacuolated cytoplasm.
Ten enzyme
deficiencies
have been identified to date and are classified into
seven types or syndromes
.
All are transmitted as
autosomal recessive
traits
except for
Hunter
syndrome (MPS 2), which
is
X-linked
recessive
.
Diagnosis
is made either by an assay of
the specific
enzyme in plasma or serum or by tissue culture
using fibroblasts
or leukocytes
.
Management is mainly supportive
and symptomatic
; however,
mucopolysaccharidoses
are
potentially amenable
to enzyme replacement therapy and to
procedures such
as bone marrow transplantation or gene
transfer.
1-Hurler
syndrome (MPS 1
) is caused by a deficiency
of l-iduronidase
that leads to the accumulation of heparan
sulfate and
dermatan sulfate
.
Clinical manifestations include
corneal clouding
, abnormal facies, hepatosplenomegaly, mental retardation
, dysostosis
multiplex, joint stiffness, and hernias.
Radiographic features
include a broadening and shortening
of long
bones; hypoplasia and fractures of the
lumbar
vertebrae
, causing
kyphosis; and enlargement of the sella turcica.
Death usually
occurs during the first decade of life.
Slide6363
2-Hunter
syndrome (MPS 2)
results from a deficiency
of iduronate-2-sulfatase
, which leads to an accumulation
of heparan
sulfate and dermatan sulfate.
The
syndrome is
similar to
Hurler syndrome, but corneal clouding is not seen.
Survival to
adulthood may occur
.
3-Morquio
syndrome (MPS 4)
is attributable to a
deficiency of
N-acetylgalactosamine-6-sulfatase or of
β-galactosidase
,
which results
in excessive urinary excretion of keratan sulfate
.
Clinical manifestations
include spondyloepiphyseal dysplasia.
Spinal cord
compression caused by hypoplasia of the odontoid
process and
cervical dislocation are common and may be the cause
of death.
OTOLOGIC Manifestations
Hearing loss in MPS is usually conductive and sensorineural.
The conductive component is attributable to serous
otitis media
as a result of dysfunction of the eustachian tube
and chronic
thickening of the mucosa of the middle ear
Unresorbed mesenchyme has been described in
the middle
ear and mastoid in
Hurler
syndrome,
and large
cells with
vacuolated cytoplasm have been described in the
middle ear
mucosa in both
Hunter
and
Hurler
syndromes.
The cause
of SNHL is unknown, but it has been attributed to abnormal
metabolism within neural element
Slide6464
Hunter syndrome in a 24-year-old man. The middle
ear contains an effusion (EF) as a result of eustachian tube dysfunction. The submucosa (SM) is thickened, and the posterior mesotympanum (PM) contains unresorbed mesenchymal tissue (×11).
PM
EF
SM
Slide6565
2-GoutGout is a metabolic disease that results from the deposition of crystals of monosodium urate within joint spaces and cutaneous structures. The crystals stimulate production of interleukin-1 and other cytokines by monocytes and macrophages, which leads to inflammation and tissue damage.Patients with gout invariably have hyperuricemia (serum urate level >7 mg/dL). Genetic factors influence the renal clearance of uric acid and may be involved in the familial incidence of hyperuricemia and gout. More recent studies have implicated loci on the X chromosome and on chromosome 16 in the pathogenesis of hyperuricemia. Other risk factors for gout include alcohol use, exposure to lead, use of diuretics, hypertension, and renal insufficiency.
IV--STORAGE AND METABOLIC DISEASES
Slide6666
The clinical manifestations of gout include
acute gouty arthritis
, aggregates of
crystal in connective tissue (tophi),
urate
urolithiasis
, and, rarely, gouty
nephropathy
.
Laboratory abnormalities
hyperuricemia
,
leukocytosis
, and an elevated
ESR
The diagnosis of gout depends on the identification of urate crystals within joint fluid or within tophi under polarized light.
The treatment of acute gouty arthritis includes bed
rest
, nonsteroidal
antiinflammatory
agents, and
colchicine
.
Uricosuric drugs such as probenecid
are useful for patients with hyperuricemia as a result of the decreased renal clearance of uric acid.
Xanthine oxidase
inhibitors such as
allopurinol
are useful if excess production of uric acid is the basis of the hyperuricemia.
Otologic Manifestations
Tophaceous deposits
can occur in multiple areas in the head and neck.
The
helical rim of the pinna
is the classic site of involvement.
Such tophi are usually
asymptomatic
and do not require any
treatment
Slide6767
IV--STORAGE AND METABOLIC DISEASES
3-OCHRONOSIS
a
rare disease
caused by an
inherited lack of
the
enzyme
homogentisic acid
oxidase
The
presence of
homogentisic acid
in urine is called
alkaptonuria
The
result of this
inborn
error
of metabolism is the deposition of a
dark pigment
in
tissues that are
rich in collagen
.
Patients
often come to
medical attention
with
symptoms and signs during the
third decade
of life
.
Manifestations
include ochronotic
arthropathy
,
ocular
and
cutaneous
pigmentation, obstruction of the
genitourinary
tract by
ochronotic calculi, and
cardiovascular
manifestations as
a result
of ochronosis that affects the aortic valve.
There
is
no effective
management
or cure for the condition, and treatment
is based on
symptomatic
therapy.
Otologic Manifestations
Ochronosis has manifestations in the
external ear
, and
cartilage
is
a site of predilection for the deposition of the pigment
of ochronosis
.
Blue
or mottled-brown macules can appear on
the pinna
and in other areas of the head and neck, including
the nose
, buccal mucosa, tonsils, pharynx, larynx, and esophagus.
Slide6868
Ochronosis
Slide6969
V-COLLAGEN VASCULAR AND AUTOIMMUNE DISEASES
The ear may be a target organ in
-several
systemic (
non–organ
specific
) diseases
thought to be autoimmune in nature (e.g
., polyarteritis
nodosa, relapsing polychondritis, Cogan syndrome),
-or
it may be the sole target of an
immune-mediated (
organ-specific
) inner ear process that causes
progressive SNHL
with or without vestibular
dysfunction( described
by
McCabe,,
proposed
by
Lehnhardt in
1958
)
Histopathologic findings
in the
temporal bone in both groups of disorders are
similar
and include
destruction and degeneration of the inner ear tissues;
scattered infiltrates of lymphocytes, plasma cells, and macrophages;
focal or diffuse proliferation of fibrous tissue and bone
;
and
a variable degree of endolymphatic
hydrops.
Slide7070
V-COLLAGEN VASCULAR AND AUTOIMMUNE DISEASES
1-MULTIPLE SCLEROSIS
a
demyelinating disease of the
brain and
spinal
cord
Most
investigators believe that MS is
an immune-mediated
disorder.
The
incidence of MS
is 2 to
150 per
100,000
population with a
female
predominance.
Although the
constellation of symptoms is vast, the principal
effects related
to the ear are
hearing
loss, particularly loss of word recognition ability
,
and
vestibular
symptoms
It
is not
clear whether
these symptoms can be attributed to peripheral or
central auditory and vestibular neural
pathways.
--abnormal auditory brainstem
potentials in MS that imply interference with the
ability to make intraaural time discriminations within the
auditory CNS.
--a 48-year old
woman with MS
in which the temporal bones and
CNS pathology
were available for study.
Although the patient
had no
documented auditory symptoms, she did have a
well documented history
of vertigo
.
The inner ear structures,
both auditory
and vestibular, were normal, and the vestibular
symptomatology was
attributed to plaques within the vestibular
pathways in
the CNS
Slide7171
V-COLLAGEN VASCULAR AND AUTOIMMUNE DISEASES
2-SUSAC
SYNDROME
a
microangiopathy
that affects
the
brain
,
retina
, and
cochlea
Symptoms include
encephalopathy
,
visual defects
as a result of branch retinal
artery occlusion, and
SNHL
.
The pattern of
hearing
loss
varies
considerably and may be
rapid
or
progressive
; a
low-tone audiometric
predominance
is common.
Magnetic resonance imaging
shows supratentorial lesions of the white matter
and involvement of the corpus callosum
.
Treatment
includes
immunosuppressive
therapy and,
if
indicated,
cochlear implantation
.
Temporal
bone findings in
a 51-yearold woman
, had bilateral low-frequency SNHL. Findings
on magnetic
resonance imaging were consistent with Susac
syndrome:
Temporal bone histopathology consisted of
widespread degeneration
within the apical portion of both cochleae
and included
the inner and outer hair cells, tectorial membranes
, stria
vascularis, spiral ligament, and spiral limbus.
Capillary occlusion
within the stria vascularis was also evident, and in
contrast, the cochlear neurons were normal in appearance
.
No evidence
of endolymphatic hydrops was found, and the vestibular
end organs were normal.
Slide7272
VI-IMMUNODEFICIENCY
DISORDERS
Occasionally
, otologic manifestations
may constitute
the presenting feature of the disease
.
1-PRIMARY
OR
CONGENITAL IMMUNODEFICIENCY DISORDERS
Primary or congenital immunodeficiency disorders
constitute a
diverse group of conditions that can be subdivided into
four broad
categories.
1-Humoral
immunodeficiency disorders
are
characterized
by
the inability to produce antigen-specific antibodies.
Patients commonly have recurrent and chronic
respiratory tract
infections owing to high-grade extracellular bacteria
, such
as
Haemophilus influenzae, Streptococcus pneumoniae,
and S
. pyogenes
.
Diagnosis is based on the analysis of
immunoglobulin
subtypes
and the assessment of specific antibody production.
Management is symptomatic with appropriate
antibiotics
and
replacement therapy with
immune human serum globulin
.
Individual syndromes within the group are
classified according
to the type of immunoglobulin (Ig) deficiency,
the mode
of genetic transmission, and the specific clinical features
, including
X-linked
infantile
agammaglobulinemia (
Bruton),
autosomal-recessive
agammaglobulinemia
,
acquired agammaglobulinemia
(common variable immunodeficiency),
X-linked immunodeficiency with hyper-IgM,
and
selective
IgA deficiency
Slide7373
2-Cellular
immunodeficiency disorders
exhibit partial or
severe
deficiencies
in the function of T lymphocytes
.
Patients
with these
disorders typically have recurrent infections owing
to
intracellular
, low-grade, opportunistic pathogens
that
include
viruses
,
fungi
,
protozoa
, and
some
bacteria
.
Diagnosis
is
based on
quantitative and qualitative tests of T-cell function, and an
associated deficiency of antibody production is often present.
Syndromes include
thymic
hypoplasia (DiGeorge syndrome),
Wiskott-Aldrich syndrome,
ataxia-telangiectasia
,
chronic mucocutaneous candidiasis
,
hyperimmunoglobulinemia
E ( Job syndrome),
and severe combined immunodeficiency
.
3-Disorders of phagocyte function
are primarily disorders of neutrophils
that leave patients vulnerable to pyogenic bacterial
or fungal
infections of varying severity and chronicity
.
This
group includes
neutropenia, which may be inherited or acquired
;
if severe
, it can cause fulminant sepsis,
chemotactic
defects
that result
in pyogenic respiratory infections,
and
microbicidal
disorders such
as chronic granulomatous disease and Chediak-
Higashi syndrome.
Therapy
includes antibiotics,
neutrophil transfusions
, and bone marrow transplantation
.
Slide7474
4-Complement system defects
include deficiencies of the individual
components or of the regulatory proteins, and all complement defects are inherited (generally autosomal recessive).
Clinical features vary with the type of defect and include
recurrent
Neisseria infections (C5, C6, C7, and C9 deficiency),
Recurrent
staphylococcal infections (C3b inactivator deficiency),
Lupus like syndromes (C1, C4, and C2 deficiency),
and angioedema (C1 esterase inhibitor deficiency).
Management of these is symptomatic and supportive.
Major advances have been made in the understanding of the genetic basis and molecular mechanisms of immunodeficiency disorders. As a result, most of the more than 100 primary immunodeficiency diseases can be diagnosed by molecular
techniques. These molecular approaches have also resulted in significant insight into the pathophysiology of the various conditions, which has permitted early diagnosis of many of these conditions by neonatal screening of umbilical cord blood. The
immunodeficiency syndromes have also played a major role in
the development of human gene therapy, which is being
actively pursued
in many centers
.
Slide7575
Otologic Manifestations
Humoral immune defects result in recurrent and persistent acute and serous otitis media.
Chronic suppurative otitis media and its attendant complications may develop and is often refractory to medical and surgical therapy
A subgroup consists of children with selective
IgG subclass 2 deficiency
, who have been shown to be susceptible to recurrent episodes of otitis media.
DiGeorge
syndrome, T-cell deficiency as a result of thymic hypoplasia, can
manifest varying degrees of
anomalies of the external, middle, and inner ears
with conductive, sensorineural, or mixed hearing losses ; a high incidence of
Mondini
dysplasia is also seen in these ears.
Recurrent episodes of acute and chronic otitis media have also been described with neutrophil chemotactic defects,
microbicidal disorders (chronic granulomatous disease),
and complement system defects.
Slide7676
VI-IMMUNODEFICIENCY DISORDERS
2-ACQUIRED IMMUNODEFICIENCY SYNDROME
Acquired immunodeficiency syndrome (AIDS), which was
first recognized
in 1981, is caused by HIV, a lymphotropic
virus that
primarily attacks T-helper lymphocytes and renders
the patient
susceptible to numerous opportunistic infections
Otologic
Manifestations
--Otologic
manifestations are
infrequent
in
children
,
serous
otitis media
is
common
When otologic disease does occur, the microbiology is
similar to
that of non-AIDS patients, with the addition of
unusual opportunistic
organisms, such as protozoa, fungi, viruses,
and mycobacteria
.
Middle ear and mastoid manifestations include acute
otitis media
, acute mastoiditis, serous otitis media, and bullous myringitis;
the severity of these infections varies and depends
on the
immune status of the patient
.
External ear disease such
as otitis
externa and Kaposi sarcoma can also occur. Tissue
diagnosis by
biopsy or tympanocentesis is indicated to identify the
causative agent before initiating therapy
.
Slide7777
Pneumocystis jiroveci
is an unusual opportunistic protozoan
that is a common cause of middle ear and external ear disease in patients with AIDS
Subcutaneous masses
in the external canal or
aural polyps
that arise from the canal, the tympanic membrane, or the mesotympanum can result in conductive
hearing loss, otorrhea, or otalgia.
Presumed routes of infection include
hematogenous
spread from another source (e.g., pulmonary),
ascending
infection through the eustachian tube from pharyngeal colonization, or
airborne
transmission of the aerosolized organism directly to the external canal.
A biopsy specimen shows the characteristic organism, and the infection responds to treatment with oral
trimethoprim sulfamethoxazole
Otologic disease that results from
P. jiroveci
may be the initial and only presenting symptom of AIDS.
Slide7878
Inner ear symptoms can occur such as vertigo, tinnitus, and SNHL that includes fluctuating and sudden hearing loss.
SNHL is ascribed to various causes that include otosyphilis, cryptococcal meningitis, tuberculous meningitis, CNS toxoplasmosis, and ototoxic medication.
HIV is neurotropic and may itself be the primary cause of SNHL, and the facial nerve can be involved by herpes zoster (Ramsay Hunt syndrome).
In a study of 49 temporal bones from 25 patients with AIDS,
-low-grade otitis media in 60% of cases,
-
severe otitis media in 20%,
-
CMV inclusion-bearing cells in the inner and middle ears in 24%, labyrinthine cryptococcosis in 8%,
and Kaposi sarcoma deposits in the eighth cranial nerve in 4%.
79
GENETICALLY
DETERMINED DEFECTS
Numerous syndromic disorders secondary to genetic defects
may have otologic manifestations that consist of hearing loss or
vestibular dysfunction or both
.
Examples include
syndromes caused
by mutations in single genes (autosomal or sex linked
), mutations
in mitochondrial genes, or chromosomal abnormalities.
Such disorders are beyond the scope of this chapter, and
the reader is referred to Chapter 147 or other
sources.